Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Irish biotech launches with $21M to shuttle RNAi meds to brain
Aerska has launched with $21 million to tackle the blood-brain barrier and deliver genetic medicines to the brain.
James Waldron
Oct 1, 2025 10:34am
Novo Nordisk vs. KBP: From $1.3B deal to legal battlefield
Oct 2, 2025 3:00am
Former Abiomed CEO launches bid for Massachusetts governor
Oct 1, 2025 4:00pm
Takeda ends all cell therapy work as part of strategic shift
Oct 1, 2025 3:13pm
Fierce Pharma
Halozyme buys Elektrofi for up to $900M
Oct 1, 2025 2:36pm
NIH research grinds to a halt as government shuts down
Oct 1, 2025 12:12pm
More News
FDA snubs Fortress' Zydus-partnered Menkes disease candidate
Oct 1, 2025 12:00pm
Illumina launches AI informatics business for multi-omics data
Oct 1, 2025 11:30am
White House pledges $100M to AI pediatric cancer project
Oct 1, 2025 11:06am
BMS, Takeda join peers in push to improve AI by pooling data
Oct 1, 2025 10:34am
See more stories